3D bioprinting company to focus on ESRD

Israeli company, Nano Dimensions has just announced it is to create a subsidiary that will focus on developing solutions for End Stage Renal Disease.  You can read the full story here.

 

Amit Dror, CEO of Nano Dimension

Profile photo of Rob Finnigan

I’m an ADPKD patient who was lucky enough to have a transplant in 2003 after only eleven months of dialysis. I'm the north-west Patient Advocacy & Support Officer for the BKPA and my interests, other than my role within GMKIN, include sport, music and politics . Follow me on Twitter: @finnigr

This entry was posted in . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *